GlassScriptPhysician profile
Alison S Witkin
NPI 1508185109
$18,650.40
in general payments reported to CMS, 2019-2025
8 companies · $2,538 in 2025
The $2,538 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,015 · 2020: $3,026 · 2021: $197 · 2022: $3,689 · 2023: $7,060 · 2024: $126 · 2025: $2,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,150 · Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,150.00 |
| Food and Beverage | $573.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $9,150.00 | 2023-2025 | Opsumit |
| Actelion Pharmaceuticals US, INC. | $3,894.92 | 2019-2023 | |
| United Therapeutics Corporation | $3,374.71 | 2019-2024 | Tyvaso, Remodulin |
| Bayer Healthcare Pharmaceuticals INC. | $1,836.27 | 2019-2020 | |
| Inari Medical, INC. | $208.68 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $97.78 | 2025 | Winrevair |
| Boston Scientific Corporation | $88.04 | 2024 | Ekosonic |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Witkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.